Aldeyra Therapeutics
ALDX
#10460
Rank
S$50.02 M
Marketcap
S$0.83
Share price
2.17%
Change (1 day)
-87.10%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -S$27.88 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$41.12 Million, an increase over its 2024 earnings that were of -S$69.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$27.88 Million-32.2%
2025 -S$41.12 Million-40.77%
2024 -S$69.42 Million52.03%
2023 -S$45.67 Million-41.21%
2022 -S$77.67 Million7.67%
2021 -S$72.14 Million55.1%
2020 -S$46.51 Million-41.29%
2019 -S$79.22 Million58.81%
2018 -S$49.88 Million74.32%
2017 -S$28.62 Million19.56%
2016 -S$23.94 Million55.21%
2015 -S$15.42 Million142.32%
2014 -S$6.37 Million-137.39%
2013 S$17.01 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$7.32 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA